612 related articles for article (PubMed ID: 36781138)
21. Use of Virus-Mimicking Nanoparticles to Investigate Early Infection Events in Upper Airway 3D Models.
Pennarossa G; Fazeli A; Ledda S; Gandolfi F; Brevini TAL
Methods Mol Biol; 2021; 2273():131-138. PubMed ID: 33604849
[TBL] [Abstract][Full Text] [Related]
22. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
Oishi K; Horiuchi S; Minkoff JM; tenOever BR
J Virol; 2022 Aug; 96(15):e0076522. PubMed ID: 35862681
[TBL] [Abstract][Full Text] [Related]
23. Potential role of viral metagenomics as a surveillance tool for the early detection of emerging novel pathogens.
Mohsin H; Asif A; Fatima M; Rehman Y
Arch Microbiol; 2021 Apr; 203(3):865-872. PubMed ID: 33175192
[TBL] [Abstract][Full Text] [Related]
24. Application of the zebrafish model in human viral research.
Liu J; Yuan X; Fan C; Ma G
Virus Res; 2024 Mar; 341():199327. PubMed ID: 38262567
[TBL] [Abstract][Full Text] [Related]
25. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
[TBL] [Abstract][Full Text] [Related]
26. Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: The example of SARS-CoV-2 and monkeypox virus.
Quéromès G; Frobert E; Bouscambert-Duchamp M; Oblette A; Valette M; Billaud G; Escuret V; Lina B; Morfin F; Gaymard A
J Med Virol; 2023 Jan; 95(1):e28126. PubMed ID: 36089749
[TBL] [Abstract][Full Text] [Related]
27. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
Iwata-Yoshikawa N; Okamura T; Shimizu Y; Hasegawa H; Takeda M; Nagata N
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626688
[TBL] [Abstract][Full Text] [Related]
28. Tropism of SARS-CoV-2, SARS-CoV, and Influenza Virus in Canine Tissue Explants.
Bui CHT; Yeung HW; Ho JCW; Leung CYH; Hui KPY; Perera RAPM; Webby RJ; Schultz-Cherry SL; Nicholls JM; Peiris JSM; Chan MCW
J Infect Dis; 2021 Sep; 224(5):821-830. PubMed ID: 33395484
[TBL] [Abstract][Full Text] [Related]
29. COVID-19: Prospective Challenges and Potential Vaccines.
Shahid Nadeem M; Ali A; Al-Ghamdi MA; Depfenhart M; Azam Khan J; Zamzami MA; Nazia Murtaza B; Kazmi I; Ur Rehman M
Altern Ther Health Med; 2020 Aug; 26(S2):72-78. PubMed ID: 32845250
[TBL] [Abstract][Full Text] [Related]
30. [Neurological damage linked to coronaviruses : SARS-CoV-2 and other human coronaviruses].
Salinas S; Simonin Y
Med Sci (Paris); 2020; 36(8-9):775-782. PubMed ID: 32755537
[TBL] [Abstract][Full Text] [Related]
31. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.
Agnihothram S; Yount BL; Donaldson EF; Huynh J; Menachery VD; Gralinski LE; Graham RL; Becker MM; Tomar S; Scobey TD; Osswald HL; Whitmore A; Gopal R; Ghosh AK; Mesecar A; Zambon M; Heise M; Denison MR; Baric RS
mBio; 2014 Mar; 5(2):e00047-14. PubMed ID: 24667706
[TBL] [Abstract][Full Text] [Related]
32. Neuromasts and Olfactory Organs of Zebrafish Larvae Represent Possible Sites of SARS-CoV-2 Pseudovirus Host Cell Entry.
Choi SSA; Chan HH; Chan CM; Wang X; Webb SE; Leung KW; Tsim KWK; Miller AL
J Virol; 2022 Dec; 96(24):e0141822. PubMed ID: 36448804
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of different inactivation methods for high and low pathogenic avian influenza viruses in egg-fluids for antigen preparation.
Pawar SD; Murtadak VB; Kale SD; Shinde PV; Parkhi SS
J Virol Methods; 2015 Sep; 222():28-33. PubMed ID: 25997377
[TBL] [Abstract][Full Text] [Related]
34. Endo-Lysosomal Cation Channels and Infectious Diseases.
Chao YK; Chang SY; Grimm C
Rev Physiol Biochem Pharmacol; 2023; 185():259-276. PubMed ID: 32748124
[TBL] [Abstract][Full Text] [Related]
35. Recent Developments in Electrochemical-Impedimetric Biosensors for Virus Detection.
Štukovnik Z; Bren U
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555560
[TBL] [Abstract][Full Text] [Related]
36. Viral Inactivation with Emphasis on SARS-CoV-2 Using Physical and Chemical Disinfectants.
Fadaei A
ScientificWorldJournal; 2021; 2021():9342748. PubMed ID: 34712107
[TBL] [Abstract][Full Text] [Related]
37. Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.
Liu WJ; Xiao H; Dai L; Liu D; Chen J; Qi X; Bi Y; Shi Y; Gao GF; Liu Y
Front Med; 2021 Aug; 15(4):507-527. PubMed ID: 33860875
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
Kim CH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
[TBL] [Abstract][Full Text] [Related]
39. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
[TBL] [Abstract][Full Text] [Related]
40. Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination.
Herrmann A; Jungnickl D; Cordsmeier A; Peter AS; Überla K; Ensser A
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
